surpass cvot tirzepatide SURPASS-CVOT: better than dulagluti Frontiers | Tirzepatide's innovative applications

A new study found that semaglutide, a medication used to treat obesity and manage Type 2 diabetes, was associated with lower ideations of suicide compared to other medications.

Wegovy is now available in pill form

Envo discreto 2472h.

Associated with better metabolic outcomes including weight, glucose, BMI, and blood pressure in clinical trials

From the approval of Orlistat (Xenical) in 1999, which focused on reducing dietary fat absorption, to the emergence of highly effective incretin-based therapies such as liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound), we have witnessed a fundamental shift in how obesity is understood and treated